BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36585044)

  • 1. Kikuchi-Fujimoto-like lymphadenopathy following COVID-19 vaccine: diagnosis and management.
    Betancur V; Net J; Chapman J; Yepes M
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36585044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kikuchi-Fujimoto disease following SARS-CoV-2 vaccination.
    Ikeda K; Kakehi E; Adachi S; Kotani K
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.
    Kashiwada T; Saito Y; Terasaki Y; Shirakura Y; Shinbu K; Tanaka T; Tanaka Y; Seike M; Gemma A
    Hum Vaccin Immunother; 2022 Nov; 18(5):2071080. PubMed ID: 35583472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kikuchi-Fujimoto disease prior to childhood-systemic lupus erythematosus diagnosis].
    Martins SS; Buscatti IM; Freire PS; Cavalcante EG; Sallum AM; Campos LM; Silva CA
    Rev Bras Reumatol; 2014; 54(5):400-3. PubMed ID: 25627306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kikuchi-Fujimoto disease and systemic lupus erythematosus: the EBV connection?
    Gionanlis L; Katsounaros M; Bamihas G; Fragidis S; Veneti P; Sombolos K
    Ren Fail; 2009; 31(2):144-8. PubMed ID: 19212912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kikuchi-Fujimoto lymphadenitis: role of parvovirus B-19, Epstein-Barr virus, human herpesvirus 6, and human herpesvirus 8.
    Rosado FG; Tang YW; Hasserjian RP; McClain CM; Wang B; Mosse CA
    Hum Pathol; 2013 Feb; 44(2):255-9. PubMed ID: 22939574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful management of Kikuchi-Fujimoto disease caused by SARS-CoV-2].
    Iszlai Z; Török L; Tóth E; Karosi T
    Orv Hetil; 2022 Jul; 163(27):1061-1065. PubMed ID: 35895470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subacute necrotizing lymphadenitis or Kikuchi-Fujimoto disease].
    Viallard JF; Parrens M; Lazaro E; Caubet O; Pellegrin JL
    Presse Med; 2007 Nov; 36(11 Pt 2):1683-93. PubMed ID: 17611068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance approach.
    Rodríguez-Ferreras A; Maray I; Coya-Fernández C; Octavio-Bocigas MM; Fernández-Del Río MF; Casares-López S; Ruiz-Salazar J
    Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):278-282. PubMed ID: 36458479
    [No Abstract]   [Full Text] [Related]  

  • 10. A familial case of Kikuchi-Fujimoto disease in dizygotic twins.
    Quadir A; Peacock K; Hsu P; Singh-Grewal D; Alexander S
    Pediatr Rheumatol Online J; 2020 Aug; 18(1):62. PubMed ID: 32778173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kikuchi-Fujimoto Disease and Prognostic Implications.
    Salamat S; Chan J; Jolly K; Powell G; Harrison K; Ahanger S; Hari C
    Head Neck Pathol; 2020 Mar; 14(1):272-275. PubMed ID: 30888636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kikuchi Fujimoto Lymphadenitis: A Rare Association With COVID-19 Vaccination.
    Nair PR; Bankar NJ; Choudhary A; Shrivastava D
    Cureus; 2023 Sep; 15(9):e45979. PubMed ID: 37900436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kikuchi-Fujimoto disease].
    Dokić M; Begović V; Bojić I; Tasić O; Stamatović D
    Vojnosanit Pregl; 2003; 60(5):625-30. PubMed ID: 14608843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kikuchi-Fujimoto disease: a case report and the evaluation of diagnostic procedures.
    Xu S; Sun W; Liu J
    BMC Oral Health; 2019 Oct; 19(1):223. PubMed ID: 31638953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fever with lymphadenopathy - Kikuchi Fujimoto disease, a great masquerader: a case report.
    Dalugama C; Gawarammana IB
    J Med Case Rep; 2017 Dec; 11(1):349. PubMed ID: 29246252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of relapsing kikuchi-fujimoto disease.
    Rezayat T; Carroll MB; Ramsey BC; Smith A
    Case Rep Otolaryngol; 2013; 2013():364795. PubMed ID: 23401825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kikuchi-Fujimoto necrotizing lymphadenitis associated with cutaneous lupus erythematosus: a case report.
    Lopez C; Oliver M; Olavarria R; Sarabia MA; Chopite M
    Am J Dermatopathol; 2000 Aug; 22(4):328-33. PubMed ID: 10949458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kikuchi-Fujimoto disease triggered by Salmonella enteritidis in a child with concurrent auto-immune thyroiditis and papilloedema.
    Altinel Açoğlu E; Sari E; Şahin G; Oğuz MM; Akçaboy M; Zorlu P; Senel S
    Paediatr Int Child Health; 2018 Nov; 38(4):298-301. PubMed ID: 29307273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kikuchi-Fujimoto Diseasae: An Important Differential of Tuberculous Lymphadenitis.
    Sultan S; Mushtaq H; Manan A
    J Coll Physicians Surg Pak; 2020 Sep; 30(9):987-988. PubMed ID: 33036688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kikuchi-Fujimoto disease type lymph node reaction with increased plasmacytoid dendritic cells may appear as a side effect following COVID-19 vaccination: Report of a case and literature review.
    Moreno de Juan G; Pérez Del Barrio A; Herrera Romero EG; González Ruiz M; Montes Moreno S
    Rev Esp Patol; 2024; 57(1):42-47. PubMed ID: 38246709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.